WEDNESDAY, March 16, 2022 (HealthDay News) — Ever since routine prostate-specific antigen (PSA) screening tests have no longer been recommended, there has been a troubling rise in advanced prostate cancer cases in the United States, new research has found. The tests measure the amount of PSA in the blood, and elevated levels can signal the … Read more
But preventable cases of the disease could surge in black and Asian groups, analysis suggests. Source link
WEDNESDAY, Feb. 9, 2022 (HealthDay News) — An experimental therapy that harnesses the body’s tumor-fighting immune cells may be effective for some women with advanced breast cancer, early research suggests. The findings come from an ongoing trial at the U.S. National Cancer Institute (NCI). It is testing a new approach to treating women whose breast … Read more
Routine checks for cervical cancer may help uncover other tumours elsewhere, research suggests. Source link
Jan. 12, 2022 — A recent headline about dramatic reductions in cervical cancer among young women as a result of the HPV vaccine did not tell the whole story of how vaccination could also have an impact on many other cancer types. Even with the good news of cervical cancer rates dropping dramatically, HPV is … Read more
Washington: Immune checkpoint inhibitors, which unleash the immune response against tumor cells, have revolutionized cancer treatment; however, the medications aren’t effective in a large number of patients, including those with colorectal cancer. New research published in the journal PNAS that was led by investigators at Massachusetts General Hospital (MGH) and the University of Geneva (UNIGE) … Read more
Photo Credit: DNY59 / Getty Images SOURCES: Amanda Maddalone, financial planning program manager, Family Reach. American Cancer Society: “Treating Breast Cancer,” “The Costs of Cancer: Addressing Patient Costs,” “Follow up Care After Breast Cancer Treatment,” “Will My Insurance Cover Alternative and Complementary Therapies?” American Health & Drug Benefits: “Comparison of Treatment Costs for Breast Cancer, … Read more
By Robert PreidtHealthDay Reporter WEDNESDAY, Aug. 11, 2021 (HealthDay News) — Immunotherapy helped extend the lives of some patients with the most common type of advanced colon cancer, researchers report. The new findings are important, they noted, because immunotherapy doesn’t typically work against microsatellite stable (MSS) colon cancer. These patients have few treatment options once … Read more
By Amy Norton HealthDay Reporter MONDAY, Aug. 9, 2021 (HealthDay News) — An experimental gel has shown early promise in treating the most common form of skin cancer — hinting at a potential alternative to surgery in the future. Researchers tested the gel in 30 patients with basal cell carcinoma (BCC), a skin cancer diagnosed … Read more
By Dennis Thompson HealthDay Reporter FRIDAY, June 4, 2021 (HealthDay News) — A twice-daily pill can dramatically reduce the risk of breast cancer recurrence in women who are genetically prone to the disease, researchers report. The pill — olaparib (Lynparza) — works by blocking a natural enzyme called PARP … Read more